Patient blood management in the cardiac surgical setting: An updated overview

Transfusion and Apheresis Science

Volumn 58, Issue 4, 2019, Pages 397-407

  Terwindt, L E ^a   Karlas, A A ^a   Eberl, S ^a   Wijnberge, M ^a   Driessen, A H G ^a   Veelo, D P ^a   Geerts, B F ^a   Hollmann, M W ^a   Vlaar, A P J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anticoagulation; Blood transfusion; Cardiac surgery; Coagulation factors; Fibrinogen; Hemostasis; Point of care tests; Prothrombin complex concentrates; Transfusion thresholds

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; ERYTHROPOIETIN; FIBRINOGEN; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; PROTHROMBIN COMPLEX; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ANEMIA; ANTICOAGULANT THERAPY; ANTICOAGULATION; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; EVIDENCE BASED PRACTICE; HEART SURGERY; HEMODILUTION; HEMOPHILIA; HEMOSTASIS; HUMAN; IRON THERAPY; OPERATIVE BLOOD LOSS; PERSONALIZED MEDICINE; POINT OF CARE TESTING; PREOPERATIVE PERIOD; PROCESS OPTIMIZATION; REVIEW; RISK ASSESSMENT; SURGICAL PATIENT; THROMBOCYTE TRANSFUSION; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT OUTCOME; PERIOPERATIVE PERIOD;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; HEMOSTASIS; HUMANS; PERIOPERATIVE CARE;

EID: 85068217378     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2019.06.015     Document Type: Review

References (77)

1. Mazer, C.D., Whitlock, R.P., Fergusson, D.A., Hall, J., Belley-Cote, E., Connolly, K., et al. Restrictive or liberal red-cell transfusion for cardiac surgery. NEJM 377 (2017), 2133–2144.
2. Bennett-Guerrero, E., Zhao, Y., O'Brien, S.M., Ferguson, T.B. Jr, Peterson, E.D., Gammie, J.S., Song, H.K., Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 304 (2010), 1568–1575.
3. Gombotz, H., Rehak, P.H., Shander, A., Hofmann, A., Blood use in elective surgery: the Austrian benchmark study. Transfusion 47 (2007), 1468–1480.
4. Hofmann, A., Farmer, S., Towler, S.C., Strategies to preempt and reduce the use of blood products: an Australian perspective. Curr Opin Anaesthesiol 25 (2012), 66–73.
5. Barile, L., Fominskiy, E., Di Tomasso, N., Alpìzar Castro, L.E., Landoni, G., De Luca, M., et al. Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized trials. Anesth Analg 124 (2017), 743–752.
6. Wells, A.W., Llewelyn, C.A., Casbard, A., Johnson, A.J., Amin, M., Ballard, S., et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med 19 (2009), 315–328.
7. Vlaar, A.P., Juffermans, N.P., Transfusion-related acute lung injury: a clinical review. Lancet 382 (2013), 984–994.
8. Bosboom, J.J., Klanderman, R.B., Zijp, M., Hollmann, M.W., Veelo, D.P., Binnekade, J.M., et al. Incidence, risk factors, and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population: a nested case-control study. Transfusion 58 (2018), 498–506.
9. Pearse, B.L., Smith, I., Faulke, D., Wall, D., Fraser, J.F., Ryan, E.G., et al. Protocol guided bleeding management improves cardiac surgery patient outcomes. Vox Sang 109 (2015), 267–279.
10. Boer, C., Meesters, M.I., Milojevic, M., Benedetto, U., Bolliger, D., von Heymann, C., Jeppsson, A., Koster, A., Osnabrugge, R.L., Ranucci, M., Ravn, H.B., Vonk, A.B.A., Wahba, A., Pagano, D., EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Thorac Cardiovasc Surg 2018:32 (2017), 88–120.
11. Miceli, A., Romeo, F., Glauber, M., de Siena, P.M., Caputo, M., Angelini, G.D., Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg, 9, 2014, 137.
12. Hassan, N.E., Tibi, P.R., Marques, M.B., Society for the advancement of patient blood management and anesthesia & analgesia: a new collaboration and home for blood management research. Anesth Analg 123 (2016), 816–817.
13. Isbister, J.P., The three-pillar matrix of patient blood management–an overview. Best Pract Res Clin Anaesthesiol 27 (2013), 69–84.
14. Musallam, K.M., Tamim, H.M., Richards, T., Spahn, D.R., Rosendaal, F.R., Habbal, A., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378 (2011), 1396–1407.
15. Loor, G., Koch, C.G., Sabik, J.F. 3rd, Li, L., Blackstone, E.H., Implications and management of anemia in cardiac surgery: current state of knowledge. J Thorac Cardiovasc Surg 144 (2012), 538–546.
16. Engoren, M., Schwann, T.A., Habib, R.H., Neill, S.N., Vance, J.L., Likosky, D.S., The independent effects of anemia and transfusion on mortality after coronary artery bypass. Ann Thorac Surg 97 (2014), 514–520.
17. Garrido-Martín, P., Nassar-Mansur, M.I., de la Llana-Ducrós, R., Virgos-Aller, T.M., Rodríguez Fortunez, P.M., Ávalos-Pinto, R., et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg 15 (2012), 1013–1018.
18. Padmanabhan, H., Siau, K., Nevill, A.M., Morgan, I., Cotton, J., Ng, A., et al. Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial. Interact Cardiovasc Thorac Surg, 2018, ivy226.
19. Weltert, L., D'Alessandro, S., Nardella, S., Girola, F., Bellisario, A., Maselli, D., et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 139 (2010), 621–627.
20. Weltert, L., Rondinelli, B., Bello, R., Falco, M., Bellisario, A., Maselli, D., et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion 55 (2015), 1644–1654.
21. Palmer, S.C., Saglimbene, V., Mavridis, D., Salanti, G., Craig, J.C., Tonelli, M., et al. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev, 2014, Cd010590.
22. Goudie, R., Sterne, J.A., Verheyden, V., Bhabra, M., Ranucci, M., Murphy, G.J., Risk scores to facilitate preoperative prediction of transfusion and large volume blood transfusion associated with adult cardiac surgery. Br J Anaesth 114 (2015), 757–766.
23. Hastings, S., Myles, P., McIlroy, D., Aspirin and coronary artery surgery: a systematic review and meta-analysis. Br J Anaesth 115 (2015), 376–385.
24. Aboul-Hassan, S.S., Stankowski, T., Marczak, J., Peksa, M., Nawotka, M., Stanislawski, R., et al. The use of preoperative aspirin in cardiac surgery: a systematic review and meta-analysis. J Card Surg 32 (2017), 758–774.
25. Hansson, E.C., Jidéus, L., Åberg, B., Bjursten, H., Dreifaldt, M., Holmgren, A., et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eurheartj 37 (2016), 189–197.
26. Tomšič, A., Schotborgh, M.A., Manshanden, J.S.J., Li, W.W.L., et al. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. 2016.
27. Douketis, J.D., Spyropoulos, A.C., Kaatz, S., Becker, R.C., Caprini, J.A., Dunn, A.S., et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373 (2015), 823–833.
28. Hassan, K., Bayer, N., Schlingloff, F., Oberhoffer, M., Wohlmuth, P., Schmoeckel, M., et al. Bleeding complications after use of novel oral anticoagulants in patients undergoing cardiac surgery. Ann Thorac Surg 105 (2018), 702–708.
29. Kincaid, E.H., Monroe, M.L., Saliba, D.L., Kon, N.D., Byerly, W.G., Reichert, M.G., Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 76 (2003), 124–128 discussion 8.
30. Medalion, B., Frenkel, G., Patachenko, P., Hauptman, E., Sasson, L., Schachner, A., Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery. J Thorac Cardiovasc Surg 126 (2003), 1875–1879.
31. Pearse, B.L., Rickard, C.M., Keogh, S., Lin Fung, Y., A retrospective explanatory case study of the implementation of a bleeding management quality initiative, in an Australian cardiac surgery unit. Aust Crit Care 32:March (2) (2019), 92–99, 10.1016/j.aucc.2018.01.001 Epub 2018 Mar 9.
32. Ternström, L., Hyllner, M., Backlund, E., Schersten, H., Jeppsson, A., A structured blood conservation programme reduces transfusions and costs in cardiac surgery. Interact Cardiovasc Thorac Surg 19 (2014), 788–794.
33. Shehata, N., Whitlock, R., Fergusson, D.A., Thorpe, K.E., MacAdams, C., Grocott, H.P., et al. Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial. J Cardiothorac Vasc Anesth 32 (2018), 121–129.
34. Patel, N.N., Avlonitis, V.S., Jones, H.E., Reeves, B.C., Sterne, J.A.C., Murphy, G.J., Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol 2 (2015), 543–553.
35. Zindrou, D., Taylor, K.M., Bagger, J.P., Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 359 (2002), 1747–1748.
36. Marinakis, S., Van der Linden, P., Tortora, R., Massaut, J., Pierrakos, C., Wauthy, P., Outcomes from cardiac surgery in Jehovah's witness patients: experience over twenty-one years. J Cardiothorac Surg, 11, 2016, 67.
37. Song, H.K., von Heymann, C., Jespersen, C.M., Karkouti, K., Korte, W., Levy, J.H., et al. Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. Ann Thoracic Surg 97 (2014), 1630–1635.
38. Hajjar, L.A., Vincent, J.-L., Galas, F.R.B.G., Nakamura, R.E., Silva, C.M.P., Santos, M.H., et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 304 (2010), 1559–1567.
39. Slight, R.D., Nzewi, O., McClelland, D.B.L., Mankad, P.S., Red cell transfusion in elective cardiac surgery patients: where do we go from here?. BJA 102 (2009), 294–296.
40. Murphy, G.J., Pike, K., Rogers, C.A., Wordsworth, S., Stokes, E.A., Angelini, G.D., et al. Liberal or restrictive transfusion after cardiac surgery. NEJM 372 (2015), 997–1008.
41. Reeves, B.C., Murphy, G.J., Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Cardiol 23 (2008), 607–612.
42. Carson, J.L., Carless, P.A., Hebert, P.C., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 2012, CD002042.
43. Wang, G., Bainbridge, D., Martin, J., Cheng, D., The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 109 (2009), 320–330.
44. Shen, S., Zhang, J., Wang, W., Zheng, J., Xie, Y., Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. J Transl Med, 14(228), 2016.
45. Ranucci, M., Conti, D., Castelvecchio, S., Menicanti, L., Frigiola, A., Ballotta, A., et al. Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients. Ann Thorac Surg 89 (2010), 11–17.
46. Zisman, E., Eden, A., Shenderey, A., Meyer, G., Balagula, M., Ammar, R., et al. The effect of acute autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass. Eur J Anaesthesiol 26 (2009), 868–873.
47. Lier, H., Vorweg, M., Hanke, A., Gorlinger, K., Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hamostaseologie 33 (2013), 51–61.
48. Bolliger, D., Tanaka, K.A., Point-of-care coagulation testing in cardiac surgery. Semin Thromb Hemost 43 (2017), 386–396.
49. Deppe, A.-C., Weber, C., Zimmermann, J., Kuhn, E.W., Slottosch, I., Liakopoulos, O.J., et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res 203 (2016), 424–433.
50. Wikkelsoe, A.J., Afshari, A., Wetterslev, J., Brok, J., Moeller, A.M., Monitoring patients at risk of massive transfusion with Thrombelastography or Thromboelastometry: a systematic review. Anaesthesiol Scand 55 (2011), 1174–1189.
51. Wikkelsø, A., Wetterslev, J., Møller, A.M., Afshari, A., Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev, 2016, CD007871.
52. Meesters, M.I., Lance, M.D., van der Steeg, R., Boer, C., The value of the thromboelastometry heparinase assay (HEPTEM) in cardiac surgery. Thromb Haemost 114 (2015), 1058–1063.
53. Myles, P.S., Smith, J.A., Forbes, A., Silbert, B., Jayarajah, M., Painter, T., et al. Tranexamic acid in patients undergoing coronary-artery surgery. NEJM 376 (2017), 136–148.
54. Henry, D.A., Carless, P.A., Moxey, A.J., O'Connell, D., Stokes, B.J., Fergusson, D.A., Ker, K., Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 16(March (3)), 2011, CD001886, 10.1002/14651858.CD001886.pub4 Review.
55. Adler Ma, S.C., Brindle, W., Burton, G., Gallacher, S., Hong, F.C., Manelius, I., et al. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 25 (2011), 26–35.
56. Ker, K., Edwards, P., Perel, P., Shakur, H., Roberts, I., Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ (Clinical research ed), 344, 2012, e3054.
57. Desborough, M., Sandu, R., Brunskill, S.J., Doree, C., Trivella, M., Montedori, A., et al. Fresh frozen plasma for cardiovascular surgery. Cochrane Database Syst Rev, 2015, CD007614.
58. Yang, L., Stanworth, S., Hopewell, S., Doree, C., Murphy, M., Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 52 (2012), 1673–1686.
59. Demeyere, R., Gillardin, S., Arnout, J., Strengers, P.F., Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang 99 (2010), 251–260.
60. Chai-Adisaksopha, C., Hillis, C., Siegal, D.M., Movilla, R., Heddle, N., Iorio, A., et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost 116 (2016), 879–890.
61. Fariborz Farsad, B., Golpira, R., Najafi, H., Totonchi, Z., Salajegheh, S., Bakhshandeh, H., et al. Comparison between prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) for the urgent reversal of warfarin in patients with mechanical heart valves in a tertiary care cardiac center. Iran J Pharm Res 14 (2015), 877–885.
62. Tang, M., Fenger-Eriksen, C., Wierup, P., Greisen, J., Ingerslev, J., Hjortdal, V., et al. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products. Thromb Res 154 (2017), 73–79.
63. Ortmann, E., Besser, M.W., Sharples, L.D., Gerrard, C., Berman, M., Jenkins, D.P., et al. An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg 121 (2015), 26–33.
64. Arnekian, V., Camous, J., Fattal, S., Rezaiguia-Delclaux, S., Nottin, R., Stephan, F., Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 15 (2012), 382–389.
65. Cappabianca, G., Mariscalco, G., Biancari, F., Maselli, D., Papesso, F., Cottini, M., et al. Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. CritCare (Lond, Engl), 20, 2016, 5.
66. Ranucci, M., Baryshnikova, E., Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST). Br J Anaesth 116 (2016), 618–623.
67. Fassl, J., Lurati Buse, G., Filipovic, M., Reuthebuch, O., Hampl, K., Seeberger, M.D., et al. Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery. Br J Anaesth 114 (2015), 225–234.
68. Ranucci, M., Baryshnikova, E., Crapelli, G.B., Rahe-Meyer, N., Menicanti, L., Frigiola, A., et al. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. JAHA, 4, 2015, e002066.
69. Rahe-Meyer, N., Levy, J.H., Mazer, C.D., Schramko, A., Klein, A.A., Brat, R., et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth 117 (2016), 41–51.
70. Simpson, E., Lin, Y., Stanworth, S., Birchall, J., Doree, C., Hyde, C., Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev, 2012, Cd005011.
71. Boer, C., Meesters, M.I., Veerhoek, D., Vonk, A.B.A., Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth 120 (2018), 914–927.
72. Meesters, M.I., Veerhoek, D., de Jong, J.R., Boer, C., A pharmacokinetic model for protamine dosing after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 30 (2016), 1190–1195.
73. Meesters, M.I., Veerhoek, D., de Lange, F., de Vries, J.W., de Jong, J.R., Romijn, J.W., et al. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Thromb Haemost 116 (2016), 251–261.
74. Spiess, B.D., Royston, D., Levy, J.H., Fitch, J., Dietrich, W., Body, S., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44 (2004), 1143–1148.
75. Al-Khabori, M., Al-Riyami, A.Z., Baskaran, B., Siddiqi, M., Al-Sabti, H., Discriminatory power of the intraoperative cell salvage use in the prediction of platelet and plasma transfusion in patients undergoing cardiac surgery. Transfus Apher Sci 53:Oct. (2) (2015), 208–212, 10.1016/j.transci.2015.03.019 Epub 2015 Mar 28.
76. Spiess, B.D., Royston, D., Levy, J.H., Fitch, J., Dietrich, W., Body, S., Murkin, J., Nadel, A., Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44:Aug. (8) (2004), 1143–1148.
77. Meesters, M.I., Veerhoek, D., de Lange, F., de Vries, J.W., de Jong, J.R., Romijn, J.W., Kelchtermans, H., Huskens, D., van der Steeg, R., Thomas, P.W., Burtman, D.T., van Barneveld, L.J., Vonk, A.B., Boer, C., Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Thromb Haemost 116:Aug. (2) (2016), 251–261, 10.1160/TH16-02-0117 Epub 2016 Jun 9.